Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Resolving ASCUS without recourse to HPV testing: manual reprocessing of residual automated liquid-based cytology (ALBC) material using manual liquid-based cytology (MLBC).

Maksem JA, Bedrossian CW, Kurtycz D, Sewall S, Shalkham J, Dhanwada V, Lind H, Bibbo M, Weidmann J, Kane B, Shi Fu Y.

Diagn Cytopathol. 2005 Dec;33(6):434-40.

PMID:
16299747
2.

Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. A study of 608 cases.

Hong IS, Marshalleck J, Williams RH, Gaiter TE, Mielzynska-Lohnas I, Kim K.

Acta Cytol. 2002 Sep-Oct;46(5):828-34.

PMID:
12365215
3.

Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma.

Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, Alfaro M, Bratti MC, Hildesheim A, Lorincz AT, Greenberg MD, Morales J, Schiffman M.

Cancer. 1999 Apr 25;87(2):48-55.

PMID:
10227593
4.

Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.

Sherman ME, Schiffman MH, Lorincz AT, Herrero R, Hutchinson ML, Bratti C, Zahniser D, Morales J, Hildesheim A, Helgesen K, Kelly D, Alfaro M, Mena F, Balmaceda I, Mango L, Greenberg M.

Cancer. 1997 Apr 25;81(2):89-97.

PMID:
9126136
5.

Testing automated liquid-based cytology samples with a manual liquid-based cytology method using residual cell suspensions from 500 ThinPrep cases.

Maksem JA, Dhanwada V, Trueblood JE, Weidmann J, Kane B, Bolick DR, Bedrossian CW, Kurtycz DF, Stewart J 3rd.

Diagn Cytopathol. 2006 Jun;34(6):391-6.

PMID:
16680773
8.

Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).

Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D, Goldie SJ; ALTS Group.

J Natl Cancer Inst. 2006 Jan 18;98(2):92-100.

PMID:
16418511
9.

Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).

Walker JL, Wang SS, Schiffman M, Solomon D; ASCUS LSIL Triage Study Group.

Am J Obstet Gynecol. 2006 Aug;195(2):341-8.

PMID:
16890545
10.

Does the interval between papanicolaou tests influence the quality of cytology?

Jeronimo J, Khan MJ, Schiffman M, Solomon D; ALTS Group.

Cancer. 2005 Jun 25;105(3):133-8.

12.

[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].

Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7. Chinese.

PMID:
16635326
13.

Human papillomavirus testing with a liquid-based system: feasibility and comparison with reference diagnoses.

Bergeron C, Cas F, Fagnani F, Didailler-Lambert F, Poveda JD.

Acta Cytol. 2006 Jan-Feb;50(1):16-22.

PMID:
16514835
14.

"ASCUS, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection.

Sherman ME, Tabbara SO, Scott DR, Kurman RJ, Glass AG, Manos MM, Burk RD, Rush BB, Schiffman M.

Mod Pathol. 1999 Apr;12(4):335-42.

PMID:
10229496
15.
16.
17.

Effectiveness of liquid-based cytology and papanicolaou tests in a low risk population.

Lerma E, Quintana MJ, Quilez M, Esteva E, Carreras A, Bonfill X, Prat J, Calaf J.

Acta Cytol. 2007 May-Jun;51(3):399-406.

PMID:
17536542
18.
20.

Supplemental Content

Support Center